Skip to content

Tarsus Pharmaceuticals, Inc.

TARS · XNAS

CIK 1819790fmd_0795GCWMV71Q5CE0F70A7F9FW7Manufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2018 to Sep 30, 2026, 32 periods

Loading
FinancialMD terminal